title: Massive haematuria successfully managed by intravesical Ankaferd in a haemodialysis patient complicated with disseminated intravascular coagulation.
abstract: Massive haematuria is a life-threatening condition, demanding immediate management of bleeding. The mortality is very high in the case of delayed management of bleeding, especially in elderly patients with concomitant comorbidity. The treatment options of haematuria are wide, and depend on underlying conditions. However, therapeutic choices are limited in the presence of massive and intractable haematuria caused by disseminated intravascular coagulation (DIC). Ankaferd blood stopper (ABS) is a novel, commercially available, haemostatic agent, which has been approved by the Ministry of Health for local use in Turkey. Here, for the first time in the literature, we report a case of diffuse intravesical bleeding stopped by intravesical use of ABS in a 72-year-old man, haemodialysis patient complicated with sepsis and DIC.
authors.affiliation: Division of Nephrology, Department of Internal Medicine,  Selcuk University, Meram School of Medicine, Konya,  Turkey.
authors.forename: Yalcin
authors.initials: Y
authors.lastname: Solak
authors.forename: Abduzhappar
authors.initials: A
authors.lastname: Gaipov
authors.forename: Orhan
authors.initials: O
authors.lastname: Ozbek
authors.forename: Mustafa Aziz
authors.initials: MA
authors.lastname: Hassan
authors.forename: Mehdi
authors.initials: M
authors.lastname: Yeksan
mesh_terms: D000368:Aged; D004211:Disseminated Intravascular Coagulation / Q000150:complications*; D006417:Hematuria / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D008297:Male; D010936:Plant Extracts / Q000627:therapeutic use*; D006435:Renal Dialysis; D012720:Severity of Illness Index
chemical_list: D010936:Plant Extracts; C539751:ankaferd blood stopper